New eczema cream tested for safety in kids
NCT ID NCT05186805
Summary
This study tested the safety and how much of a new topical cream called tapinarof gets into the body when used by children with widespread atopic dermatitis (eczema). 36 children aged 2 to 17 applied the cream daily for 4 weeks. The main goal was to check for side effects and measure the drug levels in the blood, while also seeing if the eczema improved.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dermavant Investigative Site
Thousand Oaks, California, 91320, United States
-
Dermavant Investigative Site
Centennial, Colorado, 80112, United States
-
Dermavant Investigative Site
Coral Gables, Florida, 33146, United States
-
Dermavant Investigative Site
Hialeah, Florida, 33016, United States
-
Dermavant Investigative Site
Miami Lakes, Florida, 33014, United States
-
Dermavant Investigative Site
Chicago, Illinois, 60611, United States
-
Dermavant Investigative Site
Summerville, South Carolina, 29445, United States
-
Dermavant Investigative Site
Houston, Texas, 77030, United States
-
Dermavant Investigative Site
San Antonio, Texas, 78213, United States
-
Dermavant Investigative Site
Calgary, Alberta, T3A 2N1, Canada
Conditions
Explore the condition pages connected to this study.